Drug Shortage Report for SANDOZ BOSENTAN

Last updated on 2018-04-13 History
Report ID 38711
Drug Identification Number 02386275
Brand name SANDOZ BOSENTAN
Common or Proper name BOSENTAN
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) BOSENTAN
Strength(s) 62.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4X15'S
ATC code C02KX
ATC description OTHER ANTIHYPERTENSIVES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-01-19
Estimated end date 2018-03-02
Actual end date 2018-03-23
Shortage status Resolved
Updated date 2018-04-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-04-13 French Compare
v3 2018-04-13 English Compare
v2 2018-02-05 French Compare
v1 2018-02-05 English Compare

Showing 1 to 4 of 4